Press Releases Latest Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders Press Releases Year None202420232022202120202019201820172016201520142013 Aug 03, 2017 Theratechnologies Issues Reminder Regarding Warrant Expiry Jul 24, 2017 Theratechnologies Announces New Findings with the Investigational Antiretroviral Ibalizumab and with EGRIFTA® (tesamorelin for injection) Jul 12, 2017 Theratechnologies Announces Financial Results For The Second Quarter Of 2017 Jul 05, 2017 Theratechnologies To Announce Financial Results For The Second Quarter Of 2017 Jun 30, 2017 FDA Grants Priority Review to HIV Monoclonal Antibody and Long-Acting Investigational Antiretroviral Ibalizumab May 16, 2017 Announcements in Conjunction With Theratechnologies Annual Meeting May 16, 2017 Shareholders Elect New Board Member During Theratechnologies’ Annual Meeting May 03, 2017 Theratechnologies Partner Submits Biologics License Application for HIV Monoclonal Antibody and Long-Acting Investigational Antiretroviral Ibalizumab Apr 06, 2017 Theratechnologies Announces Financial Results for First Quarter of 2017 Mar 30, 2017 Theratechnologies to Announce Financial Results for the First Quarter of 2017 First page « Previous page ‹ … Page 23 Page 24 Page 25 Page 26 Current page 27 Page 28 Page 29 Page 30 Page 31 … Next page › Last page » Displaying 261 - 270 of 360
Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
Jul 24, 2017 Theratechnologies Announces New Findings with the Investigational Antiretroviral Ibalizumab and with EGRIFTA® (tesamorelin for injection)
Jun 30, 2017 FDA Grants Priority Review to HIV Monoclonal Antibody and Long-Acting Investigational Antiretroviral Ibalizumab
May 03, 2017 Theratechnologies Partner Submits Biologics License Application for HIV Monoclonal Antibody and Long-Acting Investigational Antiretroviral Ibalizumab